due to the Company incurred cost of fund from debentures and loan increase. Summary of Financial Statement of Positions 31-Dec-17 31-Dec-18 Change MB % MB % MB % Assets Cash and cash equivalents 6.0 0.2
share-Owners of the Company (0.10 ) (0.07 ) (0.03) (40.56%) Attributable to Owners of the Company (84.18) (59.89) (24.29 ) (40.56%) Non-controlling interests - - - - 1. Operating revenue In summary
at the previous year and increase loss by 17% compare to Q1/16. 2 2. Financial Performance Summary – by business Revenues by business Q2/2017 Q2/2016 YoY THB’000 THB’000 Distributor of medical devices
11,497,220 10.02 Purchase from other persons No.of shares Price Amount Shareholding Proportion (shares) (Baht/share) (Baht) (%) Total 1,397 2,870 4,009,390 3.49 (8) Summary of Fame Line Company Limited
, equivalent to 5.7% and 6.3% of total revenue, respectively. Summary of selling and administrative expenses are as follows: Description Selling and Administrative expenses ( THB MB ) Y-O-Y Change Increase
Administrative Expenses The company’s selling and administrative expenses amounted to THB 58.9 MB and THB 60.8 MB in 2016 and 2017 respectively, equivalent to 6.3% and 6.7% of total revenue, respectively. Summary
2562 15 ตุลาคม 2562 [ส่วนที่ 1] - ข้อมูลสรุป (Executive Summary) (doc,docx,xls,xlsx) 03 พฤษภาคม 2562 15 ตุลาคม 2562 [ส่วนที่ 2.1] - วัตถุประสงค์การใช้เงิน (doc,docx,xls,xlsx) 03 พฤษภาคม 2562 15 ตุลาคม
control such as utilities expenses and marketing expenses. Summary of Financial Statement of Positions 31 Dec 2018 31 Mar 2019 Change MB. % MB. % MB. % Cash and cash equivalents 21.4 0.9% 23.4 1.0% 2.0 9.3
Limited (“the Company”) would like to submit this Management Discussion and Analysis for the three-month period ended 31 March 2019 with details as follows: Summary overview In the first quarter of 2019
Company has net profit of Baht 191 million in Q1/2018. Financial Performance Summary – by business Revenues by business THB’000 Consolidated Q1/2019 Q1/2018 ∆% Distributor of medical devices and equipment